Abate, Andrea
 Distribuzione geografica
Continente #
NA - Nord America 2.987
AS - Asia 1.212
EU - Europa 1.110
SA - Sud America 192
Continente sconosciuto - Info sul continente non disponibili 66
AF - Africa 25
OC - Oceania 13
Totale 5.605
Nazione #
US - Stati Uniti d'America 2.871
SG - Singapore 446
IT - Italia 342
CN - Cina 306
BR - Brasile 144
DE - Germania 140
PL - Polonia 140
FI - Finlandia 124
VN - Vietnam 90
HK - Hong Kong 85
GB - Regno Unito 76
BD - Bangladesh 71
CA - Canada 64
IN - India 56
FR - Francia 52
RU - Federazione Russa 47
SE - Svezia 36
TR - Turchia 33
UA - Ucraina 33
JP - Giappone 26
NL - Olanda 19
ID - Indonesia 18
IE - Irlanda 17
MX - Messico 14
AR - Argentina 12
ES - Italia 12
IL - Israele 12
IQ - Iraq 12
AU - Australia 11
BE - Belgio 11
CH - Svizzera 11
VE - Venezuela 11
CL - Cile 9
EC - Ecuador 9
ZA - Sudafrica 9
CZ - Repubblica Ceca 8
PK - Pakistan 8
DK - Danimarca 7
LT - Lituania 7
TH - Thailandia 7
AT - Austria 5
CR - Costa Rica 5
HN - Honduras 5
JM - Giamaica 5
KR - Corea 5
PT - Portogallo 5
SA - Arabia Saudita 5
CO - Colombia 4
EE - Estonia 4
EG - Egitto 4
GT - Guatemala 4
JO - Giordania 4
MA - Marocco 4
PR - Porto Rico 4
AE - Emirati Arabi Uniti 3
HU - Ungheria 3
LB - Libano 3
NI - Nicaragua 3
NP - Nepal 3
PS - Palestinian Territory 3
RO - Romania 3
BS - Bahamas 2
CW - ???statistics.table.value.countryCode.CW??? 2
DZ - Algeria 2
GP - Guadalupe 2
KZ - Kazakistan 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
OM - Oman 2
PH - Filippine 2
RS - Serbia 2
SC - Seychelles 2
SV - El Salvador 2
TN - Tunisia 2
TW - Taiwan 2
UZ - Uzbekistan 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BH - Bahrain 1
BM - Bermuda 1
ET - Etiopia 1
GD - Grenada 1
GY - Guiana 1
HT - Haiti 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LV - Lettonia 1
MC - Monaco 1
MY - Malesia 1
NO - Norvegia 1
PY - Paraguay 1
QA - Qatar 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.542
Città #
Ashburn 243
Singapore 236
San Jose 206
Chicago 178
Council Bluffs 160
Warsaw 138
Dallas 133
Los Angeles 124
New York 99
Helsinki 85
Hong Kong 83
Fairfield 81
Beijing 79
Brescia 79
Salt Lake City 77
Secaucus 64
The Dalles 60
Chandler 59
Seattle 48
Munich 45
Tampa 38
West Jordan 38
Woodbridge 37
Elk Grove Village 36
Santa Clara 36
Columbus 35
Wilmington 33
Buffalo 32
Houston 31
Des Moines 29
Lauterbourg 28
Ho Chi Minh City 27
Shanghai 26
Turku 26
Milan 25
Istanbul 24
Jacksonville 24
Princeton 24
Rome 23
Cambridge 22
Sterling 22
Tokyo 22
Lancaster 19
Moscow 18
San Francisco 18
Dublin 17
Hanoi 17
North Bergen 17
Phoenix 17
Boardman 15
Brooklyn 15
Jakarta 15
Montreal 14
Pune 14
Frankfurt am Main 13
Bergamo 12
Atlanta 11
Brussels 11
Dalmine 11
Orem 11
Redondo Beach 11
São Paulo 11
Amsterdam 10
Ann Arbor 10
Dong Ket 10
Las Vegas 10
Chennai 9
Denver 9
Lappeenranta 9
Romola 9
San Diego 9
Brno 8
London 8
Miami 8
Naples 8
New Delhi 8
Nuremberg 8
Banstead 7
Detroit 7
Dulles 7
Kansas City 7
Kyiv 7
Philadelphia 7
Poplar 7
Stockholm 7
Calcinate 6
Da Nang 6
Dearborn 6
Düsseldorf 6
Haiphong 6
Indianapolis 6
Johannesburg 6
Mumbai 6
Pescara 6
Pittsburgh 6
Rio de Janeiro 6
Bangkok 5
Boston 5
Charlotte 5
Hangzhou 5
Totale 3.477
Nome #
Cytotoxic Effect of Progesterone, Tamoxifen and Their Combination in Experimental Cell Models of Human Adrenocortical Cancer 809
Adrenocortical carcinoma xenograft in zebrafish embryos as model to study the in vivo cytotoxicity of abiraterone acetate 339
Are we failing in treatment of adrenocortical carcinoma? Lights and shadows of molecular signatures 276
In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures☆ 266
AdrenoCortical Carcinoma: in search of new pharmacological strategies 260
Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells 242
Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma. 215
Cisplatin Cytotoxicity in Human Testicular Germ Cell Tumor Cell Lines Is Enhanced by the CDK4/6 Inhibitor Palbociclib 187
A Comprehensive Investigation of Steroidogenic Signaling in Classical and New Experimental Cell Models of Adrenocortical Carcinoma 186
Ribociclib Cytotoxicity Alone Or Combined With Progesterone And/Or Mitotane In In Vitro Adrenocortical Carcinoma Cells 161
Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art? 142
Outcome of brain metastases from adrenocortical carcinoma: a pooled analysis 140
Preclinical Evidence of Progesterone as a New Pharmacological Strategy in Human Adrenocortical Carcinoma Cell Lines 140
Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen 139
Feasibility and Activity of Megestrol Acetate in Addition to Etoposide, Doxorubicin, Cisplatin, and Mitotane as First-Line Therapy in Patients with Metastatic/Unresectable Adrenocortical Carcinoma with Low Performance Status 139
Novel cellular systems unveil mucosal melanoma initiating cells and a role for PI3K/Akt/mTOR pathway in mucosal melanoma fitness 131
Estrogen-Like Effect of Mitotane Explained by Its Agonist Activity on Estrogen Receptor-α 131
Cytotoxic effects of targeted agent alone or with chemotherapy in the treatment of adenoid cystic carcinoma: a preclinical study 127
Trabectedin impairs invasiveness and metastasis in adrenocortical carcinoma preclinical models 123
The CDK Inhibitor Dinaciclib Improves Cisplatin Response in Nonseminomatous Testicular Cancer: A Preclinical Study 120
An update on adrenocortical cell lines of human origin 118
Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma 118
Correction to: A Comprehensive Investigation of Steroidogenic Signaling in Classical and New Experimental Cell Models of Adrenocortical Carcinoma (Cells, (2022), 11, 9, (1439), 10.3390/cells11091439) 115
Cancer cell xenografts in zebrafish embryos as an experimental tool in drug screening for adrenocortical carcinoma 105
A Database Tool Integrating Genomic and Pharmacologic Data from Adrenocortical Carcinoma (ACC) Cell Lines, PDX, and Patient Samples 100
Dlk1 is a novel adrenocortical stem/progenitor cell marker that predicts malignancy in adrenocortical carcinoma 99
RETROSPECTIVE ANALYSIS OF THE PATIENT-REPORTED ADVERSE DRUG REACTIONS IN AN ITALIAN ALLERGY UNIT: ALLERG-RAF STUDY 93
FGF/FGFR inhibitors downmodulates c-Myc oncoprotein and hampers the growth of adrenocortical carcinoma 88
Chemo-immunotherapy with cisplatin and nivolumab as second-line approach in metastatic adrenocortical carcinoma 84
Human and Murine Cell Lines for Adrenocortical Carcinoma and Pheochromocytoma 77
Correlation Between iXip and Final Pathology in Patients Affected by Prostate Cancer Undergoing Radical Prostatectomy: A Multicenter Prospective Trial (PROXIMA—PROstate iXip Index Multicenter Analysis) 51
null 51
Prognostic role of pretreatment [18F]FDG PET/CT in patients affected by adrenocortical carcinoma and treated with chemotherapy 49
(Non)canonical Wnt signaling, cytoarchitecture and stemness: new insights from primary nonmetastatic, primary metastatic, regional and distant metastatic models of adrenocortical carcinoma 45
Preclinical evaluation of progesterone combined with EDP-M scheme in 2D and 3D models of adrenocortical carcinoma 42
Pharmacological WEE1 inhibition as a strategy to overcome cisplatin resistance in non-seminoma testicular cancer: insights from preclinical models 38
Primary Adrenal Malignancies 27
Updating ACC preclinical models: characterization of two new patient-derived cell lines 20
NEAT1: A multifaceted long non-coding RNA in multiple myeloma 12
Totale 5.605
Categoria #
all - tutte 22.353
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.353


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022116 0 0 0 0 6 13 11 4 4 31 17 30
2022/2023173 27 10 13 13 17 32 4 19 25 1 4 8
2023/2024393 14 12 28 26 24 72 11 48 46 53 16 43
2024/20251.475 47 25 19 156 66 61 47 41 141 56 283 533
2025/20262.144 145 248 194 201 184 152 295 114 151 208 149 103
2026/2027714 93 72 147 337 65 0 0 0 0 0 0 0
Totale 5.605